Bradley L. Campbell - 21 Jun 2022 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chief Operating Officer, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
21 Jun 2022
Net transactions value
-$106,173
Form type
4
Filing time
22 Jun 2022, 19:01:45 UTC
Previous filing
22 Mar 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Options Exercise $57,927 +16,410 +2.4% $3.53 706,028 21 Jun 2022 Direct
transaction FOLD Common Stock Sale $164,100 -16,410 -2.3% $10.00 689,618 21 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Options Exercise $0 -16,410 -33% $0.000000 32,835 21 Jun 2022 Common Stock 16,410 $3.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 All of the options were fully vested and exercisable as of the transaction date.